Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mongol Em Impex Concern (MEIC) is the leading pharmaceutical company in Mongolia, established in 1923 as the state-owned central pharmaceutical supplier. The company operates across the entire value chain, including the import, distribution, and manufacturing of essential medicines and medical equipment. MEIC maintains a vast network of pharmacies and distribution centers throughout Mongolia, ensuring the supply of high-quality healthcare products to both urban and rural populations. In addition to its distribution business, the company operates manufacturing facilities that produce a range of generic drugs and traditional Mongolian medicines. MEIC is a key partner for international pharmaceutical giants, facilitating the entry of global brands into the Mongolian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mongolia Pharmaceutical.